RE: Britain for sale23 Jan 2024 09:37
Investors chronicle view:
Despite having a slim portfolio of drugs, pharmaceutical group Indivior (INDV) is reasonably confident about future sales growth. This is because most of its medicines treat one increasingly prevalent condition in North American markets: opioid use disorder.